|
|
|
The Institute for
Applied Biomedicine (formerly the Santa Cruz AIDS Research
Foundation) is developing drugs to treat immune system diseases
including AIDS. We are a growing not-for-profit biotechnology firm
committed to making our drugs accessible to all.
AIDS
We are in pre-clinical testing for a new AIDS drug, which
is designed to keep the immune system of an HIV-positive
person healthy. Initial test results have been clearly
positive. |
|
 |
 |
 |
|
Autoimmune Diseases
We are developing treatments for autoimmune diseases such as
rheumatoid arthritis and lupus. We have filed for patent
protection on our broad, immune-modifying technology. |
- Overview - an overview of
our organization and research, with links to more
detailed information.
- Product Pipeline - the
Institute's drugs for immune system diseases other than AIDS; drug
development plans.
- Our AIDS Drug: Immudel™-gp120 -
the Institute's experimental AIDS drug; results of pilot tests;
drug development plans; the Institute's Medical
Hypotheses article
and references; expert
review; general information about AIDS; AIDS-related annotated
links. Information on both non-technical and technical levels.
- Support Our Research - on-line
and off-line donations, volunteering, and other opportunities
to support our research and drug development; confidential
mailing list.
Please Contact Us via email, phone,
fax, or mail with questions, comments, or
tax-deductible contributions.
This web site designed and maintained by
Michael Toppa
© 1997-2003
Institute for Applied Biomedicine. All Rights Reserved. Legal Notices.
|
 |